AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimer... (ddition to searching for new medicines w...)

HOME >> MEDICINE >> NEWS

AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimer's Disease

Date:7/16/2009

ddition to searching for new medicines, we urgently need to find new ways to identify those at risk of developing Alzheimer's disease before they begin to experience symptoms. In addition to developing a novel approach to diagnosing cognitive decline, we hope that our collaboration with the world-class researchers at The Mental Health Research Institute will provide insights that aid our search for new treatments and ways to prevent disease progression."

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. For more information about AstraZeneca, please visit: http://www.astrazeneca.com/

About AIBL

The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) aims to improve understanding of the causes and diagnosis of Alzheimer's disease, and help develop preventative strategies. The study, consisting of a patient cohort of 1112 participants, will help researchers develop and confirm a set of diagnostic markers biomarkers and psychometrics that can be used to objectively monitor disease progression and to develop hypotheses about diet and lifestyle factors that might delay the onset of this disease. For more information, please visit: www.aibl.csiro.au

About MHRI

The Mental Health Research Institute (MHRI) located in Melbourne is Australia's
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
2. Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
3. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
4. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
5. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
6. AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities
7. AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
8. Ingenuity Systems Announces Multi-Year Deal With AstraZeneca
9. Court Grants AstraZeneca Temporary Restraining Order Against Apotex in PULMICORT RESPULES Patent Litigation
10. FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site
11. AstraZenecas David Brennan Elected PhRMA Board Chairman

Post Your Comments:

(Date:5/17/2013)... Lake Arrowhead, CA (PRWEB) May 17, 2013 ... without extra health complications, but for diabetics, treatment is ... diabetics involves additional medical care to monitor blood sugar ... an addicted diabetic properly, a drug rehab for ... the unique dietary and nutritional needs of the diabetic, ...

(Date:5/17/2013)... sleep on mood, memory and learning was given ... Intel International Science and Engineering Fair (ISEF)the world,s ... awards are coordinated by the National Institute on ... of Health, and Friends of NIDA, a coalition ... Science Awards were presented at a ceremony Thursday ...

(Date:5/17/2013)... (HealthDay News) -- Too few obstetrics-gynecology residents in the ... lead to care issues for the rapidly growing number ... Researchers surveyed 510 ob/gyn residents and found that fewer ... menopause medicine, even though seven in 10 would like ... of fourth-year residents -- those soon to complete their ...

(Date:5/17/2013)... Working with lab mice models of multiple sclerosis (MS), ... for the design of drugs that could be safer ... , The findings of the research study, published ... could have therapeutic applications for MS as well ... loss of white matter, which is the brain tissue ...

(Date:5/17/2013)... The IUD safety advocates at DrugRisks.com are announcing ... the vaginal ring contraceptive NuvaRing. A recent report from ... blood clots from the devices has risen*. ... patients using popular prescription devices by providing the latest ... out if others are experiencing similar side effects and ...

Breaking Medicine News(10 mins):Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2 Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3 Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 2 Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 3 Health News:Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award 4 Health News:Is Menopause Overlooked in U.S. Medical Schools? 2 Health News:Study identifies new approach to improving treatment for MS and other conditions 2 Health News:Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes 2

[0] Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics [0] Study of 'screen time' on mood, memory, and cognition wins top NIH Addiction Science Award [0] Is Menopause Overlooked in U.S. Medical Schools?[0] Study identifies new approach to improving treatment for MS and other conditions [0] Latest Court Records Show 6% Increase In NuvaRing Lawsuits, DrugRisks Notes

... 5:30 PM WED., FEB. 13 AT MARRIOTT,ADDRESS LEGISLATORS 8:30 ... LEGISLATIVE LEADERS, AND CRC HEALTH GROUP CEO DR. BARRY ... General,Barry McCaffrey (ret.), the former White House Drug Czar ... the national media, will,spearhead a Feb. 13-14 West Virginia ...

... women, those with pregnancy-induced high blood pressure were found ... blood pressure in the pieces of tissue linking mother ... Baptist Medical Center. The finding, reported online in the ... , Preeclampsia, or high blood pressure induced by pregnancy, ...

... analysis, it may be possible in the future for radiologists ... Erik Vidholm at Uppsala University has been involved in ... and plan the treatment of cancer, for instance. , Computerized ... organs like the liver, or to construct three-dimensional models of ...

... Translation chat improves cross-language customer support and collaboration, ... announced today that,PetlinQ(TM), a web-based application used to ... referring physicians, has signed on,to use the new ... first Internet chat translation service that,seamlessly integrates automated ...

... Program of CGT-2168, MENLO PARK, Calif., ... a distinguished international panel of medical experts ... with overseeing COGENT,the company,s global Phase 3 ... product CGT-2168., (Logo: http://www.newscom.com/cgi-bin/prnh/20071112/COGENTUSLOGO ), ...

... BETHESDA, Md., Feb. 8 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: ... healthcare,services and products in the People,s Republic of China, ... ended December 31, 2007,including a 473% increase and a ... the quarter ended December 31, 2007 was $36.0 million, ...

4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, and Dr. Barry Karlin, Nation's #1 Drug Treatment Provider, to Spearhead Drug Treatment WVA Advocacy Day Feb 13-14; 142,000 Need, Don't Get Treatment in State New finding may help explain development of preeclampsia Doctors will soon be able to feel organs via a display screen PetlinQ Signs Agreement With SpeakLike for Accurate, Real-Time Translation Chat Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program Chindex International, Inc. Announces Results for the Quarter and Nine Months Ended December 31, 2007

(Date:5/17/2013)... , May 17, 2013 Serving a region of ... Rico , Caribbean Imaging and Radiation Therapy (CIRT, ... therapy capabilities with the acquisition of an Elekta Versa HD™ ... Versa HD offers clinicians the versatility to deliver conventional therapies ... while also enabling treatment of highly complex cancers that require ...

(Date:5/17/2013)... , May 17, 2013 Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...

(Date:5/17/2013)... 2013 Boston Scientific Corporation (NYSE: BSX ... Scientific Program May 21-24 in Paris ... particularly rich and diversified set of data this year ... M.D., global chief medical officer, Boston Scientific. "The primary ... the NG PROMUS trial, which evaluated our Promus PREMIER ...

Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8

[0] Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients [0] Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference [0] Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013

... Acuo Technologies®, a market leading provider of ... for archiving, collaboration and migration services, is pleased ... of its market leading Vendor Neutral Archive software ... cloud-enablement, workflow services, and improved performance and scalability. ...

... Data Group,s (IDG) Computerworld announces Kaiser ... officer, care delivery, and Mike Brady, senior vice ... IT Leader honorees. This year,s Premier 100 spotlights ... sides of companies for their exceptional technology leadership, ...

Cached Medicine Technology:Acuo Technologies Announces New Enterprise Capabilities with Latest Software Release 2 Computerworld Names Kaiser Permanente's Lisa Caplan and Mike Brady to Premier 100 2 Computerworld Names Kaiser Permanente's Lisa Caplan and Mike Brady to Premier 100 3 Computerworld Names Kaiser Permanente's Lisa Caplan and Mike Brady to Premier 100 4

Acuo Technologies Announces New Enterprise Capabilities with Latest Software Release Computerworld Names Kaiser Permanente's Lisa Caplan and Mike Brady to Premier 100

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

Medicine Products:

Surgical Pathology Consultation Sulfonylurea Hypoglycemics, Urine Sulfonylurea Hypoglycemics, Serum or Plasma Sulfhemoglobin, Whole Blood